DIAGNOS (CVE:ADK) Reaches New 12-Month High – Here’s Why

Shares of DIAGNOS Inc. (CVE:ADK) reached a new 52-week high on Wednesday . The stock traded as high as C$0.45 and last traded at C$0.44, with a volume of 236448 shares. The stock had previously closed at C$0.41.

DIAGNOS Price Performance

The company has a market cap of C$52.98 million, a price-to-earnings ratio of -11.00 and a beta of -0.14. The company has a quick ratio of 0.68, a current ratio of 1.49 and a debt-to-equity ratio of 204.05. The company’s fifty day moving average price is C$0.29 and its two-hundred day moving average price is C$0.27.

Insider Buying and Selling at DIAGNOS

In other DIAGNOS news, Director Robert Dunn purchased 200,000 shares of the firm’s stock in a transaction dated Wednesday, July 29th. The stock was bought at an average cost of C$0.30 per share, with a total value of C$60,000.00. Following the purchase, the director directly owned 2,117,778 shares of the company’s stock, valued at C$635,333.40. The trade was a 10.43% increase in their ownership of the stock. Over the last three months, insiders have purchased 328,571 shares of company stock worth $96,000. 16.81% of the stock is owned by company insiders.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.